Home Conference Coverage

Conference Coverage

Conference Coverage

Substantial Survival Improvement with Axicabtagene Ciloleucel in r/r Follicular Lymphoma

Editorial Team - June 12, 2021

Valemetostat Promises Durable Tumor Response in Peripheral T-Cell Lymphoma and T-Cell Leukemia

Study with [Vic-]Trastuzumab Duocarmazine Meets Primary Endpoint

Toripalimab + Standard of Care Delays Disease Progression in Advanced Nasopharyngeal Carcinoma

Immunotherapy After Surgery Extends Disease-Free Survival for Select Patients With Kidney Cancer

A Study of the 4-1BB Agonist ATOR-1017 Shows Positive Results

Editorial Team - June 6, 2021

Cancer Patients Concerned About Vaccine Despite Few Adverse Effects

Editorial Team - June 6, 2021

Blood test

New Saliva Test Detects Head and Neck Cancer – Shows Promising...

Editorial Team - June 6, 2021

Single and Dual Immunotherapy Regimens May Offer Improved Overall Survival in...

Editorial Team - June 5, 2021

Advancing Treatment Options with Immunotherapies in Non-Hodgkin’s Lymphoma

Editorial Team - June 5, 2021

General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

Comprehensive Genomic and Transcriptomic Profiling Predicts Pan-Tumor Benefit of Pembrolizumab

Editorial Team - June 5, 2021

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Max Gersh.

Improved OS with Bemarituzumab + Chemotherapy In FGFR2b+ Gastric and Gastroesophageal...

Editorial Team - June 4, 2021

Attendees during the day at the American Society of Clinical Oncology (ASCO) Courtesy: ? ASCO/Scott Morgan.

Novel Targeted Treatment For Patients With KRAS G12C-Mutated Lung Cancer

Editorial Team - June 4, 2021

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019. ASCO/Luke Franke 2019.

Immunotherapy Resistance in Leiomyosarcoma: Subtypes may Benefit From Personalized Treatments

Peter Hofland, Ph.D - June 4, 2021

Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection

Peter Hofland, Ph.D - May 19, 2021

12 3...37 Page 1 of 37

LATEST NEWS

Regular Blood Monitoring and a Tailored Treatment Approach in Mycosis Fungoides and Sézary Syndrome

Editorial Team - July 22, 2021

The National Cancer Act at 50: The Greatest Scientific Discovery Effort in History.

Peter Hofland, Ph.D - July 21, 2021

In States that Expanded Medicaid Cancer Mortality Rates Declined More Steeply

Editorial Team - July 21, 2021

Breakthrough Therapy Designation for Venetoclax + Azacitidine in Myelodysplastic Syndromes

Editorial Team - July 20, 2021

Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy

Editorial Team - July 18, 2021

Press Releases | Cancer

Local Breast Cancer Patients Experiencing Faster Recovery With PRMA’s... July 23, 2021
PRMA’s ERAS Protocol significantly decreases patient’s postoperative pain after breast reconstruction.(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/local_breast_cancer_patients_experiencing_faster_recovery_with_prmas_new_recovery_protocol/prweb18088964.htm
Mount Sinai Researchers Develop Novel Therapy That Could Be Effective... July 23, 2021
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer...(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_researchers_develop_novel_therapy_that_could_be_effective_in_many_cancers/prweb18083920.htm
Deep Bio Announces Research Collaboration with a Major Cancer... July 22, 2021
Deep Bio renews Research Collaboration Agreement with Dana-Farber Cancer Institute(PRWeb July 22, 2021)Read the full story at https://www.prweb.com/releases/deep_bio_announces_research_collaboration_with_a_major_cancer_institute/prweb18081063.htm